| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $3.5M | +76.9% |
| Cost of Revenue | $2.4M | +58.7% |
| Gross Profit | $1.1M | +136.5% |
| R&D Expense | $5.1M | -27.0% |
| SG&A Expense | $7.9M | +14.1% |
| Operating Income | -$11.9M | +0.6% |
| Pre-tax Income | -$12.3M | -3.9% |
| Net Income | -$12.3M | -3.9% |
| EPS (Basic) | -$0.46 |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.5M | -72.6% |
| Accounts Receivable | $177K | — |
| Inventory | $2.6M | +52.6% |
| Current Assets | $4.6M | -36.7% |
| Total Assets | $5.4M | -33.7% |
| Current Liabilities | $2.2M | +23.5% |
| Total Liabilities | $4.5M | +146.1% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.0M | +14.5% |
| Capital Expenditures | $120K | -68.7% |
| Investing Cash Flow | -$120K | -104.5% |
| Financing Cash Flow | $7.3M | -1.8% |
| Free Cash Flow | -$11.1M | +16.1% |
| +29.2% |
| EPS (Diluted) | -$0.46 | +29.2% |
| Stockholders' Equity |
| $822K |
| -86.8% |